Overall Survival Benefits of First-Line Treatments for Asian Patients with Advanced Epidermal Growth Factor Receptor-Mutated NSCLC Harboring Exon 19 Deletion: A Systematic Review and Network Meta-Analysis.

Chan, Sik-Kwan; Choi, Horace Cheuk-Wai; Lee, Victor Ho-Fun

Chan, Sik-Kwan; Choi, Horace Cheuk-Wai; Lee, Victor Ho-Fun.

Afiliação

Chan SK; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Choi HC; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Lee VH; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Cancers (Basel) ; 14(14)2022 Jul 11.

Article em En | MEDLINE | ID: mdl-35884423

Palavras-chave

Asian; epidermal growth factor receptor; exon 19 deletion; non-small-cell lung cancer; tyrosine kinase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google